Atlas Trials

Identification of New Immune Factors Specific of Relapse in Childhood B Lineage Acute Lymphoblastic Leukemia

Clinical trial NCT02618109 · TERMINATED

Trial details

NCT number
NCT02618109
Sponsor
University Hospital, Angers
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
B Acute Lymphoblastic LeukemiaLeukemia Relapse
Start date
2016-01-01
Primary completion
2022-09-01
Enrollment
119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.